A plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC

David Planchard; Pasi A. Jänne; Ying Cheng; James Chih Hsin Yang; Noriko Yanagitani; Sang We Kim; Shunichi Sugawara; Yan Yu; Yun Fan; Sarayut Lucien Geater; Konstantin Laktionov; Chee Khoon Lee; Natalia Valdiviezo; Samreen Ahmed; Jean Marc Maurel; Igor Andrasina; Jonathan Goldman; Dana Ghiorghiu; Yuri Rukazenkov; Alex Todd; Kunihiko Kobayashi

doi:10.1080/14796694.2025.2463880

A plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC

David Planchard, Pasi A. Jänne, Ying Cheng, James Chih Hsin Yang, Noriko Yanagitani, Sang We Kim, Shunichi Sugawara, Yan Yu, Yun Fan, Sarayut Lucien Geater, Konstantin Laktionov, Chee Khoon Lee, Natalia Valdiviezo, Samreen Ahmed, Jean Marc Maurel, Igor Andrasina, Jonathan Goldman, Dana Ghiorghiu, Yuri Rukazenkov, Alex ToddKunihiko Kobayashi

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

langue originale	Anglais
journal	Future Oncology
Les DOIs	https://doi.org/10.1080/14796694.2025.2463880
état	Accepté/sous presse - 1 janv. 2025

Accès au document

10.1080/14796694.2025.2463880

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Planchard, D., Jänne, P. A., Cheng, Y., Yang, J. C. H., Yanagitani, N., Kim, S. W., Sugawara, S., Yu, Y., Fan, Y., Geater, S. L., Laktionov, K., Lee, C. K., Valdiviezo, N., Ahmed, S., Maurel, J. M., Andrasina, I., Goldman, J., Ghiorghiu, D., Rukazenkov, Y., ... Kobayashi, K. (Accepté/en presse). A plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC. Future Oncology. https://doi.org/10.1080/14796694.2025.2463880

@article{ef85d0e77a564eae8a5676d030276f73,

title = "A plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC",

author = "David Planchard and J{\"a}nne, {Pasi A.} and Ying Cheng and Yang, {James Chih Hsin} and Noriko Yanagitani and Kim, {Sang We} and Shunichi Sugawara and Yan Yu and Yun Fan and Geater, {Sarayut Lucien} and Konstantin Laktionov and Lee, {Chee Khoon} and Natalia Valdiviezo and Samreen Ahmed and Maurel, {Jean Marc} and Igor Andrasina and Jonathan Goldman and Dana Ghiorghiu and Yuri Rukazenkov and Alex Todd and Kunihiko Kobayashi",

year = "2025",

month = jan,

day = "1",

doi = "10.1080/14796694.2025.2463880",

language = "English",

journal = "Future Oncology",

issn = "1479-6694",

}

Planchard, D, Jänne, PA, Cheng, Y, Yang, JCH, Yanagitani, N, Kim, SW, Sugawara, S, Yu, Y, Fan, Y, Geater, SL, Laktionov, K, Lee, CK, Valdiviezo, N, Ahmed, S, Maurel, JM, Andrasina, I, Goldman, J, Ghiorghiu, D, Rukazenkov, Y, Todd, A & Kobayashi, K 2025, 'A plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC', Future Oncology. https://doi.org/10.1080/14796694.2025.2463880

TY - JOUR

T1 - A plain language summary of results from the FLAURA2 study

T2 - Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC

AU - Planchard, David

AU - Jänne, Pasi A.

AU - Cheng, Ying

AU - Yang, James Chih Hsin

AU - Yanagitani, Noriko

AU - Kim, Sang We

AU - Sugawara, Shunichi

AU - Yu, Yan

AU - Fan, Yun

AU - Geater, Sarayut Lucien

AU - Laktionov, Konstantin

AU - Lee, Chee Khoon

AU - Valdiviezo, Natalia

AU - Ahmed, Samreen

AU - Maurel, Jean Marc

AU - Andrasina, Igor

AU - Goldman, Jonathan

AU - Ghiorghiu, Dana

AU - Rukazenkov, Yuri

AU - Todd, Alex

AU - Kobayashi, Kunihiko

PY - 2025/1/1

Y1 - 2025/1/1

UR - http://www.scopus.com/inward/record.url?scp=86000032384&partnerID=8YFLogxK

U2 - 10.1080/14796694.2025.2463880

DO - 10.1080/14796694.2025.2463880

M3 - Article

C2 - 39995095

AN - SCOPUS:86000032384

SN - 1479-6694

JO - Future Oncology

JF - Future Oncology

ER -